BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9006320)

  • 1. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
    Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
    Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.
    Wienecke R; Maize JC; Shoarinejad F; Vass WC; Reed J; Bonifacino JS; Resau JH; de Gunzburg J; Yeung RS; DeClue JE
    Oncogene; 1996 Sep; 13(5):913-23. PubMed ID: 8806680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT; Reddy AJ; Zhang J; Gutmann DH
    Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
    Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
    Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
    Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
    Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hamartin and tuberin expression in human tissues.
    Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV
    Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of the tuberous sclerosis gene-2 product during neuronal differentiation.
    Soucek T; Hölzl G; Bernaschek G; Hengstschläger M
    Oncogene; 1998 Apr; 16(17):2197-204. PubMed ID: 9619828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
    Zhang Y; Gao X; Saucedo LJ; Ru B; Edgar BA; Pan D
    Nat Cell Biol; 2003 Jun; 5(6):578-81. PubMed ID: 12771962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
    Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
    Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.
    Mizuguchi M; Mori M; Nozaki Y; Momoi MY; Itoh M; Takashima S; Hino O
    Acta Neuropathol; 2004 Jan; 107(1):47-52. PubMed ID: 14566415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
    Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
    Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Rap1 GTPase in astrocyte growth regulation.
    Apicelli AJ; Uhlmann EJ; Baldwin RL; Ding H; Nagy A; Guha A; Gutmann DH
    Glia; 2003 May; 42(3):225-34. PubMed ID: 12673829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues.
    Menchine M; Emelin JK; Mischel PS; Haag TA; Norman MG; Pepkowitz SH; Welsh CT; Townsend JJ; Vinters HV
    Mod Pathol; 1996 Nov; 9(11):1071-80. PubMed ID: 8933518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.